Authors:
ROTHER M
ERKINJUNTTI T
ROESSNER M
KITTNER B
MARCUSSON J
KARLSSON I
Citation: M. Rother et al., PROPENTOFYLLINE IN THE TREATMENT OF ALZHEIMERS-DISEASE AND VASCULAR DEMENTIA - A REVIEW OF PHASE-III TRIALS, Dementia and geriatric cognitive disorders, 9, 1998, pp. 36-43
Authors:
LUHR H
ROTHER M
IYEMORI T
HANSEN TL
LEPPING RP
Citation: H. Luhr et al., SUPERPOSED EPOCH ANALYSIS APPLIED TO LARGE-AMPLITUDE TRAVELING CONVECTION VORTICES, Annales geophysicae, 16(7), 1998, pp. 743-753
Citation: A. Wimo et al., ECONOMIC-IMPACT OF INTRODUCING PROPENTOFYLLINE FOR THE TREATMENT OF DEMENTIA IN SWEDEN, Clinical therapeutics, 20(3), 1998, pp. 552-566
Authors:
MARCUSSON J
ROTHER M
KITTNER B
ROSSNER M
SMITH RJ
BABIC T
FOLNEGOVICSMALC V
MOLLER HJ
LABS KH
Citation: J. Marcusson et al., A 12-MONTH, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PROPENTOFYLLINE (HWA-285) IN PATIENTS WITH DEMENTIA ACCORDING TO DSM III-R, Dementia and geriatric cognitive disorders, 8(5), 1997, pp. 320-328
Authors:
NEBEL CE
ROGG J
KELLY MK
DAHLHEIMER B
ROTHER M
BICHLER M
WEGSCHEIDER W
STUTZMANN M
Citation: Ce. Nebel et al., REALIZATION OF ALGAAS ANTIDOT ARRAYS BY PULSED-LASER INTERFERENCE GRATINGS, Journal of applied physics, 82(3), 1997, pp. 1497-1499
Authors:
NEBEL CE
ROTHER M
STUTZMANN M
SUMMONTE C
HEINTZE M
Citation: Ce. Nebel et al., THE SIGN OF THE HALL-EFFECT IN HYDROGENATED AMORPHOUS AND DISORDERED CRYSTALLINE SILICON, Philosophical magazine letters, 74(6), 1996, pp. 455-463
Authors:
ROTHER M
KESSLER J
FUNKE M
ROTHER I
WINDISCH M
Citation: M. Rother et al., MEMORY IMPAIRMENT AFTER HYPERVENTILATION - A PHYSIOLOGICAL MODEL OF COGNITIVE DYSFUNCTIONS, Neurobiology of aging, 15, 1994, pp. 190000092-190000092
Citation: M. Gross et al., THE APPLICATION OF COHERENCE ANALYSIS IN THE STUDY OF SLEEP EEG OF NEWBORNS WITH DIFFERENT PERINATAL RISK, EEG-EMG, 24(4), 1993, pp. 247-251